NEW YORK – Silexion Therapeutics on Friday revealed plans to clinically develop its siRNA candidate SIL204 as a treatment for KRAS-driven pancreatic cancer. The firm said recent preclinical studies of ...

Dell Precision 5520 is a Windows 10 Professional laptop with a 15.60-inch display that has a resolution of 3840x2160 pixels. It is powered by a Core i7 processor and it comes with 16GB of RAM. The ...

EnPlusOne Biosciences, Inc., a biotechnology company harnessing the power of enzymes to deliver better RNA at scale, today ...

This report provides insights for biotech and pharmaceutical companies leveraging RNA-based precision medicine to ... to accelerate the development of siRNA therapeutics. Unlocking the Potential ...

Creative Biolabs Modifying exosome surfaces and precision cargo loading technologies enhance targeted delivery, which advances disease trea ...

This report provides insights for biotech and pharmaceutical companies leveraging RNA-based precision medicine to ... en/ Unlocking the Potential of siRNA for Drug Development siRNA therapeutics ...

LONDON, March 05, 2025--Silence Therapeutics plc, Nasdaq: SLN ("Silence" or the "Company"), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, today ...

EMA orphan drug designation is awarded to drugs intended to treat rare diseases that are life-threatening or chronically ...

Atalanta Therapeutics, a biotechnology company pioneering RNA interference (RNAi) for the treatment of neurological diseases, today announced the publication of preclinical data in the journal ...

Nanotechnology offers a next-gen solution to plant genome editing challenges by enabling precise, efficient delivery of CRISPR, RNA, and DNA tools using nanoparticles like AuNPs, CNTs, and lipid ...